Gli1 and Gli2 control the expression of Bmi‐1 by their binding to the Bmi‐1 promoter and eventually upregulating multidrug‐resistant proteins that promote chemoresistance in glioma cells [47, 48]. The gene discussed is BMI1; the disease is glioma.